Ola A El-Feky

@r.search.yahoo.com

Biochemistry Department, Faculty of Pharmacy Tanta University
Lecturer of Biochemistry

Ola A El-Feky


                  Download Compact PDF  
https://researchid.co/olael-feky

RESEARCH, TEACHING, or OTHER INTERESTS

Biochemistry, Molecular Biology, Clinical Biochemistry, Cancer Research
18

Scopus Publications

305

Scholar Citations

9

Scholar h-index

8

Scholar i10-index

Scopus Publications

  • Curcumin targets miR-21-3p: promising therapeutic strategy for treatment of benign prostatic hyperplasia
    Nahla E. El-Ashmawy, Ibrahim M. Elazab, Eman G. Khedr, Ola A. El-Feky
    Molecular Biology Reports, 2026
  • Resistance to doxorubicin therapy in breast cancer cells could be attenuated by ligustilide: impact on autophagy and LncRNA H19
    Eman A. Amr, Ola A. El-Feky, Eman G. Khedr, Nahla E. El-Ashmawy
    BMC Complementary Medicine and Therapies, 2026
    Background Resistance to DOX in breast cancer (BC) treatment is attributed to multiple mechanisms. The potential of autophagy inhibition in mitigating DOX resistance in BC has yet to be clarified. Despite showing anti-tumorigenic activity, the role of ligustilide (LIG) in BC treatment remains limited. Aim To evaluate LIG-mediated autophagy inhibition in DOX-treated MCF-7, MCF-7/DOX, and MDA-MB-231 cells, and investigate LncRNA H19’s role in BC resistance. Methods The three cell lines were treated with DOX, LIG, or both of them. Autophagic flux and expression of ERα, metastasis-associated protein (MTA1) complex components, autophagy-related 7 gene ( ATG7 ), multidrug resistance gene 1 ( MDR1 ) and LncRNA H19 were assessed. Key findings Both individual treatments showed dose-dependent cytotoxicity. When combined together, LIG increased DOX cytotoxicity in MCF-7/DOX and MDA-MB-231. LIG inhibited DOX-induced autophagic flux, indicated by elevated LC3BII and p62 levels, and reversed MDR1 in MCF-7/DOX and MDA-MB-231. LIG monotherapy upregulated ERα in MCF-7/DOX and restored its expression in MDA-MB-231. In MCF-7/DOX, combined treatment upregulated ERα and downregulated LncRNA H19 relative to DOX monotherapy, whereas in MDA-MB-231, it upregulated LncRNA H19 compared with DOX monotherapy. Conclusion LIG mitigated DOX-induced resistance through inhibiting autophagy, restoring ERα expression, and downregulating LncRNA H19 in the DOX-resistant BC cell line, thereby presenting a potential therapeutic approach in BC treatment.
  • Targeting miR-133-3p via mesenchymal stem cells-derived exosomes as a novel cell-free therapy for testosterone-induced benign prostatic hyperplasia
    Ibrahim M. Elazab, Nahla E. El-Ashmawy, Ola A. El-Feky, Eman G. Khedr
    International Journal of Biochemistry and Cell Biology, 2026
  • Autophagy-related genes and encoded proteins' prognostic significance in various cancer types: A molecular perspective
    Eman A. Amr, Ola A. El-Feky, Nahla E. El-Ashmawy, Eman G. Khedr
    Biochimica Et Biophysica Acta Gene Regulatory Mechanisms, 2026
  • Synergistic anticancer effects of cisplatin and phenolic aglycones of the aerial part of Rumex dentatus L. in tongue squamous cell carcinoma: insights from network pharmacology and biological verification
    Amany E. Ragab, Ghada M. Al-Ashmawy, Sherin R. El Afify, Ola A. El-Feky, Amera O. Ibrahim
    BMC Complementary Medicine and Therapies, 2025
    Background Oral squamous cell carcinoma (OSCC) ranks as the sixth most common malignancy globally. Cisplatin is the standard chemotherapy for OSCC, but resistance often reduces its efficacy, necessitating new treatments with fewer side effects. Rumex dentatus L., from the Polygonaceae family, is known for its medicinal properties, but its anticancer potential has not been thoroughly explored. This study aimed to investigate the synergy between cisplatin and an extract from the aerial parts of R. dentatus L. in treating tongue carcinoma (HNO97) in vitro, using network pharmacology, biological verification, and phytochemical analysis. Methods The study included UPLC-ESI–MS/MS analysis, cytotoxicity assays, cell cycle analysis, apoptosis assessment, and RT-qPCR for gene expression of Bcl2, p53, and ATG7. Potential targets were identified, and mechanisms of action were examined through online databases and enrichment analyses. Results The R. dentatus L. extract contained 14 phenolic aglycons. Combining cisplatin and R. dentatus L. was more effective in inhibiting proliferation, inducing cell cycle arrest and apoptosis, and reducing autophagy in HNO97 cells than cisplatin alone. KEGG analysis indicated that the drug combination might work through pathways like PI3K-Akt signaling, microRNAs in cancer, and EGFR tyrosine kinase inhibitor resistance. Conclusions Combining cisplatin with R. dentatus L. may be a promising approach for treating tongue carcinoma by affecting multiple pathways, providing a new perspective for developing more effective treatments for OSCC.
  • New insights into Baricitinib's immunomodulatory role in doxorubicin-induced cardiomyopathy: JAK/STAT and TLR-4/NF-κB pathways
    Eman G. Khedr, Noha H. Badr, Ola A. El-Feky
    Archives of Biochemistry and Biophysics, 2025
  • Targeting immune checkpoints as a new therapeutic strategy for intra-hepatic cholangiocarcinoma
    Eman G. Khedr, Mariam A. Abo Seif, Othman F. Abdelzaher, Ahmed B. M. Mehany, Ola A. El-Feky
    Bioimpacts, 2025
    Introduction: Intrahepatic cholangiocarcinoma (IH-CCA) is a malignancy characterized with limited response to standard chemotherapeutic strategies due to development of drug resistance. We aim to investigate new immune-therapeutic strategy through using AUNP-12 as an immune checkpoint blocker in chemically induced IH-CCA mice model. Methods: Mice were randomly divided into 2 groups; normal control group and disease group. The disease group was further subdivided into 5 subgroups assigned according to treatment modality. The Immunotherapeutic mechanism of AUNP-12 was investigated through analysis of PD-1/PD-L1 levels and IFN-γ Levels in the tumor microenvironment. Immunohistochemical analysis of CD3+T lymphocytes and TGF-β was performed. Results: We reported that AUNP-12 significantly decreased levels of PD-1/PD-L1 at the site of tumor with subsequent activation of CD3+T lymphocytes that secrete IFN-γ which specifically lysis tumor cells. AUNP-12 also acts through downregulation of TGF-β signaling in IH-CCA mice group treated with AUNP-12. Conclusion: Our data indicated that AUNP-12 effectively harbors IH-CCA progression and improves the survival rate of mice. AUNP-12 acts as an immune check point blocker that specifically inhibits PD-1/PD-L1 binding, activates cytotoxic T-lymphocytes, and downregulates TGF-β signaling pathway.
  • Prostate cancer and the cell cycle: Focusing on the role of microRNAs
    Ibrahim M. Elazab, Ola A. El-Feky, Eman G. Khedr, Nahla E. El-Ashmawy
    Gene, 2024
  • Cancer chemo-preventive role of grape seed oil and cisplatin as a combination adjuvant therapy in the treatment of tongue squamous cell carcinoma: A biological in-vitro study
    Ghada Mohammad Al-Ashmawy, Doaa A. Labah, Omneya Mohamed Wahba, Muhammad T. Abdel Ghafar, Ola A. El-Feky
    Archives of Oral Biology, 2023
    OBJECTIVES: Grape seed oil (GSO) has recently gained popularity due to its anticancer properties. This study aimed to investigate the efficacy of combining cisplatin (CP) and GSO in tongue squamous cell carcinoma (TSCC) treatment. METHODS: In this study, human tongue carcinoma cell line (HNO-97) was treated with CP and GSO alone or in combination. The effects of CP and GSO on cytotoxicity and cell cycle arrest were studied using the MTT assay and flowcytometry, respectively. The apoptotic markers, including p53 and caspase 8, were assessed using reverse-transcription polymerase chain reaction (RT-PCR), caspase 3 using immunohistochemistry, and the angiogenic marker vascular endothelial growth factor (VEGF) using enzyme-linked immunosorbent assay (ELISA). RESULTS: The IC50 drug concentrations were found to be 16.4 ug/mL of GSO and 2.18 ug/mL of CP. When compared to the untreated control group, the percentage of S phase cells and apoptotic cells was significantly higher in the GSO, CP, and GSO/CP combination therapy groups. Furthermore, p53, caspase 8, caspase 3 expression were significantly upregulated in the GSO-and CP-treated groups, with evident upregulation with GSO/CP combination therapy. However, VEGF levels were significantly lower in the GSO-, CP-, and combined GSO/CP-treated groups. CONCLUSIONS: GSO has both an apoptotic and antiangiogenic effect in the treatment of TSCC, suggesting a new strategy for phytochemical-based combination therapy.
  • Elucidation of Natural Components of Gardenia thunbergia Thunb. Leaves: Effect of Methanol Extract and Rutin on Non-Alcoholic Fatty Liver Disease
    Eman M. EL-Shial, Amal Kabbash, Mona El-Aasr, Ola A. El-Feky, Suzy A. El-Sherbeni
    Molecules, 2023
    The rising prevalence of non-alcoholic fatty liver disease NAFLD has strained the healthcare system. Natural products could solve this problem, so the current study focused on the impact of G. thunbergia Thunb. against this ailment. LC–ESI–MS/MS revealed the phytochemical profile of the methanol extract from Gardenia thunbergia leaves (GME). Forty-eight compounds were tentatively identified, and stigmasterol, fucosterol, ursolic acid, and rutin were isolated. The separation of the last three compounds from this plant had not before been achieved. The anti-NAFLD effect of the methanol extract of the leaves of G. thunbergia, and its major metabolite, rutin, was assessed in mice against high-fructose diet (HFD)-induced obesity. Male mice were allocated into nine groups: (1) saline (control), (2) 30% fructose (diseased group), (3) HFD, and 10 mg/kg of simvastatin. Groups 4–6 were administered HFD and rutin 50, 75, and 100 mg/kg. Groups (7–9) were administered HFD and methanol extract of leaves 100, 200, and 300 mg/kg. Methanol extract of G. thunbergia leaves at 200 mg/kg, and rutin at 75 mg/kg significantly reduced HFD-induced increments in mice weight and hepatic damage indicators (AST and ALT), steatosis, and hypertrophy. The levels of total cholesterol, LDL–C, and triglycerides in the blood decreased. In addition, the expressions of CYP2E1, JNK1, and iNOS in the diseased mice were downregulated. This study found that GME and rutin could ameliorate NAFLD in HFD-fed mice, with results comparable to simvastatin, validating G. thunbergia’s hepatoprotective effects.
  • Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1
    Mariam Ali Abo-Saif, Amany E. Ragab, Amera O. Ibrahim, Othman F. Abdelzaher, Ahmed B. M. Mehanyd, Maha Saber-Ayad, Ola A. El-Feky
    Frontiers in Pharmacology, 2023
  • l-Carnitine Mitigates Trazadone Induced Rat Cardiotoxicity Mediated via Modulation of Autophagy and Oxidative Stress
    Naglaa F. Khedr, Ola A. El-Feky, Rehab H. Werida
    Cardiovascular Toxicology, 2022
  • Biological Effect of Quercetin in Repairing Brain Damage and Cerebral Changes in Rats: Molecular Docking and in Vivo Studies
    Ahmed B. M. Mehany, Amany Belal, Eman Y. Santali, Salwa Shaaban, Mohammad A. S. Abourehab, Ola A. El-Feky, Mahmoud Diab, Fawzy M. A. Abou Galala, Eslam B. Elkaeed, Ghada Abdelhamid
    Biomed Research International, 2022
  • Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors
    Abdallah E. Abdallah, Reda R. Mabrouk, Maged Mohammed Saleh Al Ward, Sally I. Eissa, Eslam B. Elkaeed, Ahmed B. M. Mehany, Mariam A. Abo-Saif, Ola A. El-Feky, Mohamed S. Alesawy, Mohamed Ayman El-Zahabi
    Journal of Enzyme Inhibition and Medicinal Chemistry, 2022
  • Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer
    Nahla E. El-Ashmawy, Fatma Z. Hussien, Ola A. El-Feky, Sara M. Hamouda, Ghada M. Al-Ashmawy
    Life Sciences, 2020
  • Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study
    N. E. El-Ashmawy, E. A. El-Zamarany, E. G. Khedr, H. A. El-Bahrawy, O. A. El-Feky
    Clinical and Translational Oncology, 2019
  • Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study
    Nahla E. El-Ashmawy, Enas A. El-Zamarany, Eman G. Khedr, Hoda A. El-Bahrawy, Ola A. El-Feky
    Clinical and Experimental Medicine, 2018
  • Biochemical/metabolic changes associated with hepatocellular carcinoma development in mice
    Nahla E. El-Ashmawy, Hoda A. El-Bahrawy, Maha M. Shamloula, Ola A. El-Feky
    Tumor Biology, 2014

RECENT SCHOLAR PUBLICATIONS

  • Curcumin targets miR-21-3p: promising therapeutic strategy for treatment of benign prostatic hyperplasia
    NE El-Ashmawy, IM Elazab, EG Khedr, OA El-Feky
    Molecular Biology Reports 53 (1), 229 , 2026
    2026
  • Resistance to doxorubicin therapy in breast cancer cells could be attenuated by ligustilide: impact on autophagy and LncRNA H19
    EA Amr, OA El-Feky, EG Khedr, NE El-Ashmawy
    BMC Complementary Medicine and Therapies , 2026
    2026
  • Targeting miR-133-3p via Mesenchymal Stem Cells-Derived Exosomes as a Novel Cell-Free Therapy for Testosterone-Induced Benign Prostatic Hyperplasia
    IM Elazab, NE El-Ashmawy, OA El-Feky, EG Khedr
    The International Journal of Biochemistry & Cell Biology, 106959 , 2026
    2026
  • Autophagy-Related Genes and Encoded Proteins’ Prognostic Significance in Various Cancer Types: A Molecular Perspective
    N Elashmawy, EA Amr, OA El-Feky, EG Khedr
    2026
  • Autophagy-related genes and encoded proteins' prognostic significance in various cancer types: A molecular perspective
    EA Amr, OA El-Feky, NE El-Ashmawy, EG Khedr
    Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 195131 , 2025
    2025
  • New insights into Baricitinib's immunomodulatory role in doxorubicin-induced cardiomyopathy: JAK/STAT and TLR-4/NF-κB pathways
    EG Khedr, NH Badr, OA El-Feky
    Archives of Biochemistry and Biophysics 771, 110505 , 2025
    2025
    Citations: 1
  • Targeting immune checkpoints as a new therapeutic strategy for intra-hepatic cholangiocarcinoma
    EG Khedr, MAA Seif, OF Abdelzaher, ABM Mehany, OA El-Feky
    BioImpacts: BI 15, 31086 , 2025
    2025
  • The Role of Iron Homeostasis in Multiple Sclerosis
    OA El-Feky, M Aboessa, MM Elsawy
    AlSalam International Journal of Pharmacy 1 (1), 50-60 , 2025
    2025
  • Synergistic anticancer effects of cisplatin and phenolic aglycones of the aerial part of Rumex dentatus L. in tongue squamous cell carcinoma: insights from network …
    AE Ragab, GM Al-Ashmawy, SRE Afify, OA El-Feky, AO Ibrahim
    BMC Complementary Medicine and Therapies 25 (1), 25 , 2025
    2025
    Citations: 7
  • Prostate cancer and the cell cycle: Focusing on the role of microRNAs
    IM Elazab, OA El-Feky, EG Khedr, NE El-Ashmawy
    Gene 928, 148785 , 2024
    2024
    Citations: 9
  • Prostate cancer and the cell cycle: Focusing on the role of microRNAs
    N Elashmawy, IM Elazab, OA El-Feky, EG Khedr
    2024
  • Cancer chemo-preventive role of grape seed oil and cisplatin as a combination adjuvant therapy in the treatment of tongue squamous cell carcinoma: A biological in-vitro study
    GM Al-Ashmawy, DA Labah, OM Wahba, MTA Ghafar, OA El-Feky
    Archives of Oral Biology 151, 105698 , 2023
    2023
    Citations: 8
  • Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1
    MA Abo-Saif, AE Ragab, AO Ibrahim, OF Abdelzaher, ABM Mehanyd, ...
    Frontiers in pharmacology 14, 1166653 , 2023
    2023
    Citations: 48
  • Elucidation of Natural Components of Gardenia thunbergia Thunb. Leaves: Effect of Methanol Extract and Rutin on Non-Alcoholic Fatty Liver Disease
    EM El-Shial, A Kabbash, M El-Aasr, OA El-Feky, SA El-Sherbeni
    Molecules 28 (2), 879 , 2023
    2023
    Citations: 19
  • Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors
    AE Abdallah, RR Mabrouk, MMS Al Ward, SI Eissa, EB Elkaeed, ...
    Journal of enzyme inhibition and medicinal chemistry 37 (1), 573-591 , 2022
    2022
    Citations: 62
  • l -Carnitine Mitigates Trazadone Induced Rat Cardiotoxicity Mediated via Modulation of Autophagy and Oxidative Stress
    NF Khedr, OA El-Feky, RH Werida
    Cardiovascular Toxicology 22 (9), 831-841 , 2022
    2022
    Citations: 12
  • Biological effect of quercetin in repairing brain damage and cerebral changes in rats: molecular docking and in vivo studies
    ABM Mehany, A Belal, EY Santali, S Shaaban, MAS Abourehab, ...
    BioMed research international 2022 (1), 8962149 , 2022
    2022
    Citations: 31
  • Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer
    NE El-Ashmawy, FZ Hussien, OA El-Feky, SM Hamouda, GM Al-Ashmawy
    Life Sciences 259, 118193 , 2020
    2020
    Citations: 62
  • Copeptin: Promising Biomarker for Nephropathy in Type II Diabetes
    DA Ali, GM Al-Ashmawy, SM Aboelnasr, OAES El-Feky
    Journal of Advanced Medical and Pharmaceutical Research 2 (1), 1-7 , 2020
    2020
    Citations: 4
  • Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study
    NE El-Ashmawy, EA El-Zamarany, EG Khedr, HA El-Bahrawy, OA El-Feky
    Clinical and Translational Oncology 21 (5), 636-645 , 2019
    2019
    Citations: 10

MOST CITED SCHOLAR PUBLICATIONS

  • Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors
    AE Abdallah, RR Mabrouk, MMS Al Ward, SI Eissa, EB Elkaeed, ...
    Journal of enzyme inhibition and medicinal chemistry 37 (1), 573-591 , 2022
    2022
    Citations: 62
  • Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer
    NE El-Ashmawy, FZ Hussien, OA El-Feky, SM Hamouda, GM Al-Ashmawy
    Life Sciences 259, 118193 , 2020
    2020
    Citations: 62
  • Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1
    MA Abo-Saif, AE Ragab, AO Ibrahim, OF Abdelzaher, ABM Mehanyd, ...
    Frontiers in pharmacology 14, 1166653 , 2023
    2023
    Citations: 48
  • Biological effect of quercetin in repairing brain damage and cerebral changes in rats: molecular docking and in vivo studies
    ABM Mehany, A Belal, EY Santali, S Shaaban, MAS Abourehab, ...
    BioMed research international 2022 (1), 8962149 , 2022
    2022
    Citations: 31
  • Biochemical/metabolic changes associated with hepatocellular carcinoma development in mice
    NE El-Ashmawy, HA El-Bahrawy, MM Shamloula, OA El-Feky
    Tumor Biology 35 (6), 5459-5466 , 2014
    2014
    Citations: 27
  • Elucidation of Natural Components of Gardenia thunbergia Thunb. Leaves: Effect of Methanol Extract and Rutin on Non-Alcoholic Fatty Liver Disease
    EM El-Shial, A Kabbash, M El-Aasr, OA El-Feky, SA El-Sherbeni
    Molecules 28 (2), 879 , 2023
    2023
    Citations: 19
  • l -Carnitine Mitigates Trazadone Induced Rat Cardiotoxicity Mediated via Modulation of Autophagy and Oxidative Stress
    NF Khedr, OA El-Feky, RH Werida
    Cardiovascular Toxicology 22 (9), 831-841 , 2022
    2022
    Citations: 12
  • Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study
    NE El-Ashmawy, EA El-Zamarany, EG Khedr, HA El-Bahrawy, OA El-Feky
    Clinical and Translational Oncology 21 (5), 636-645 , 2019
    2019
    Citations: 10
  • Prostate cancer and the cell cycle: Focusing on the role of microRNAs
    IM Elazab, OA El-Feky, EG Khedr, NE El-Ashmawy
    Gene 928, 148785 , 2024
    2024
    Citations: 9
  • Cancer chemo-preventive role of grape seed oil and cisplatin as a combination adjuvant therapy in the treatment of tongue squamous cell carcinoma: A biological in-vitro study
    GM Al-Ashmawy, DA Labah, OM Wahba, MTA Ghafar, OA El-Feky
    Archives of Oral Biology 151, 105698 , 2023
    2023
    Citations: 8
  • Synergistic anticancer effects of cisplatin and phenolic aglycones of the aerial part of Rumex dentatus L. in tongue squamous cell carcinoma: insights from network …
    AE Ragab, GM Al-Ashmawy, SRE Afify, OA El-Feky, AO Ibrahim
    BMC Complementary Medicine and Therapies 25 (1), 25 , 2025
    2025
    Citations: 7
  • Copeptin: Promising Biomarker for Nephropathy in Type II Diabetes
    DA Ali, GM Al-Ashmawy, SM Aboelnasr, OAES El-Feky
    Journal of Advanced Medical and Pharmaceutical Research 2 (1), 1-7 , 2020
    2020
    Citations: 4
  • Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study
    NE El-Ashmawy, EA El-Zamarany, EG Khedr, HA El-Bahrawy, OA El-Feky
    Clinical and Experimental Medicine 18 (4), 535-546 , 2018
    2018
    Citations: 4
  • New insights into Baricitinib's immunomodulatory role in doxorubicin-induced cardiomyopathy: JAK/STAT and TLR-4/NF-κB pathways
    EG Khedr, NH Badr, OA El-Feky
    Archives of Biochemistry and Biophysics 771, 110505 , 2025
    2025
    Citations: 1
  • Effect of diet intake imbalance in hepatocellular carcinoma progression
    HA El-Bahrawy, NE El-Ashmawy, MM Shamloula, OA El-Feky
    International Journal of Biology 6 (2), 104-119 , 2014
    2014
    Citations: 1
  • Curcumin targets miR-21-3p: promising therapeutic strategy for treatment of benign prostatic hyperplasia
    NE El-Ashmawy, IM Elazab, EG Khedr, OA El-Feky
    Molecular Biology Reports 53 (1), 229 , 2026
    2026
  • Resistance to doxorubicin therapy in breast cancer cells could be attenuated by ligustilide: impact on autophagy and LncRNA H19
    EA Amr, OA El-Feky, EG Khedr, NE El-Ashmawy
    BMC Complementary Medicine and Therapies , 2026
    2026
  • Targeting miR-133-3p via Mesenchymal Stem Cells-Derived Exosomes as a Novel Cell-Free Therapy for Testosterone-Induced Benign Prostatic Hyperplasia
    IM Elazab, NE El-Ashmawy, OA El-Feky, EG Khedr
    The International Journal of Biochemistry & Cell Biology, 106959 , 2026
    2026
  • Autophagy-Related Genes and Encoded Proteins’ Prognostic Significance in Various Cancer Types: A Molecular Perspective
    N Elashmawy, EA Amr, OA El-Feky, EG Khedr
    2026
  • Autophagy-related genes and encoded proteins' prognostic significance in various cancer types: A molecular perspective
    EA Amr, OA El-Feky, NE El-Ashmawy, EG Khedr
    Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 195131 , 2025
    2025